Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
PharmaSave from Antwerpen, company number BE0677769484, closed financial year 2025 with a result of € 667 after tax. For that financial year PharmaSave recorded revenue of € 7,800 and equity of € 10,974. Compared with financial year 2024, the result moved from € 1,018 to € 667. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 14, 2026.
€ 10,974
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 667
▼ 34% vs 2024
Profit after tax over the fiscal year.
€ 18,818
▲ 84% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -1,426.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,418
▲ 210% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 7,800 | |
| Gross margin | € 651 | € 722 | € 1,374 | € 1,193 | ▼ 13% |
| Profit after taxes | € -277 | € 480 | € 1,018 | € 667 | ▼ 34% |
| Equity | € 8,808 | € 9,289 | € 10,307 | € 10,974 | ▲ 6% |
| Total debts | € 2,380 | € 2,717 | € 6,795 | € 9,089 | ▲ 34% |
| Cash | € 5,706 | € 11,588 | € 10,242 | € 18,818 | ▲ 84% |
| Retained profit | € -3,592 | € -3,111 | € -2,093 | € -1,426 | ▲ € 667 |
| Balance sheet total | € 11,188 | € 12,006 | € 17,102 | € 20,063 | ▲ 17% |
Key figures of PharmaSave, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PharmaSave?
What happened at PharmaSave in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 667 (▼ 34% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Sint-Gillis (bij-Brussel). KBO
- Wagner Felmming became a director. NBB
In short
From € 277 loss in 2022 to € 667 profit in 2025.
Best year ever: 2024, with € 1,018 profit.
Management
Behind PharmaSave is Wagner Felmming.
Directors
According to the 2025 annual accounts
Wagner Felmming
Director
since 2017
Establishments
Establishment units
Physical locations of this company
Oudebaan 61
2610 Antwerpen
Fonsnylaan 46 box 59
1060 Sint-Gillis (bij-Brussel)
Active since 30 June 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Abacus Medicine A/S(oprichter) 100%
Details
- Company number
- 0677.769.484
- VAT number
- BE 0677.769.484
- Registered office
- Oudebaan 61, 2610 Antwerpen
- Names & denominations
- PharmaSave
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 June 2017
- Peppol
- Not registered
- Activities · NACE
Detailhandel in farmaceutische producten